| Literature DB >> 27595647 |
Toan Nguyen1, Fei Wen Cheong2, Jonathan Wee Kent Liew2, Yee Ling Lau3.
Abstract
BACKGROUND: Despite the global effort against neglected tropical diseases (NTDs), developing countries with middle to low income are still burdened by them. Vietnam has been undergoing substantial economic growth and urbanization, but underprivileged people living in rural and suburban areas are still having little access to public health infrastructure and proper sanitation. Hitherto, limited information is available for seroprevalence and risk factors of several parasitic diseases in Vietnam.Entities:
Keywords: Cysticercosis; Fascioliasis; Seroprevalence; Southeast Asia; Strongyloidiasis; Toxocariasis
Mesh:
Substances:
Year: 2016 PMID: 27595647 PMCID: PMC5011968 DOI: 10.1186/s13071-016-1780-2
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Descriptive characteristics of the participants
| Characteristics | Fascioliasis ( | Toxocariasis ( | Strongyloidiasis ( | Cysticercosis ( |
|---|---|---|---|---|
|
|
|
|
| |
| Gender | ||||
| Male | 4,916 (48.8) | 30,698 (39.7) | 16,651 (38.8) | 5,889 (40.3) |
| Female | 5,168 (51.2) | 46,658 (60.3) | 26,269 (61.2) | 8,712 (59.7) |
| Age group (years) | ||||
| < 1 | 22 (0.2) | 120 (0.2) | 71 (0.2) | 27 (0.2) |
| 1–15 | 728 (7.2) | 12,007 (15.5) | 5,924 (13.8) | 1,750 (12.0) |
| 16–30 | 2,151 (21.3) | 19,842 (25.7) | 10,529 (24.5) | 3,482 (23.8) |
| 31–45 | 3,823 (37.9) | 26,488 (34.2) | 14,681 (34.2) | 5,328 (36.5) |
| 46–60 | 2,718 (27.0) | 15,342 (19.8) | 9,048 (21.1) | 3,132 (21.5) |
| 61–75 | 494 (4.9) | 2,908 (3.8) | 2,089 (4.9) | 695 (4.8) |
| 76–90 | 140 (1.4) | 627 (0.8) | 545 (1.3) | 175 (1.2) |
| > 90 | 8 (1.0) | 22 (< 0.1) | 33 (0.1) | 12 (0.1) |
Univariate and bivariate analysis for the association between seroprevalence of diseases and risk factors
| Risk factor | Fascioliasis | Toxocariasis | Strongyloidiasis | Cysticercosis |
|---|---|---|---|---|
|
|
|
|
| |
| Gender | ||||
| Male | 258/4,916 (5.2) | 14,533/30,698 (47.3) | 1,429/16,651 (8.6) | 330/5,889 (5.6) |
| Female | 332/5,168 (6.4) | 20,462/46,658 (43.9) | 1,745/26,269 (6.6) | 383/8,712 (4.4) |
| RR | 0.817 | 1.080 | 1.292 | 1.275 |
| (95 % CI) | (0.70–0.96) | (1.06–1.10) | (1.21–1.38) | (1.10–1.47) |
|
| 0.012 | < 0.0001 | < 0.0001 | 0.001 |
| Age group (years) | ||||
| ≤ 60 | 539/9,442 (5.7) | 33,363/73,799 (45.2) | 2,874/40,253 (7.1) | 659/13,719 (4.8) |
| > 60 | 51/642 (7.9) | 1,632/3,557 (45.9) | 300/2,667 (11.2) | 54/882 (6.1) |
| RR | 0.719 | 0.985 | 0.635 | 0.785 |
| (95 % CI) | (0.55–0.95) | (0.95–1.02) | (0.57–0.71) | (0.60–1.03) |
|
| 0.020 | 0.431 | < 0.0001 | 0.078 |
Multivariable analysis for the association between seroprevalence of diseases and risk factors
| Risk factor | Fascioliasis | Toxocariasis | Strongyloidiasis | Cysticercosis |
|---|---|---|---|---|
| OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | |
| Gender | ||||
| Male/female | 0.814 (0.69–0.96) | 1.152 (1.12–1.19) | 1.330 (1.24–1.43) | 1.297 (1.12–1.51) |
|
| 0.016 | < 0.0001 | < 0.0001 | 0.001 |
| Age group (years) | ||||
| ≤ 60/> 60 | 0.715 (0.53–0.96) | 0.964 (0.90–1.03) | 0.597 (0.53–0.68) | 0.761 (0.57–1.01) |
|
| 0.028 | 0.283 | < 0.0001 | 0.062 |
Seroprevalence of co-exposure to fascioliasis, toxocariasis, strongyloidiasis and cysticercosis
| Risk factor | F + S | F + T | C + T | S + T | C + S | C + F | F + S + T | F + S + C | C + T + S | C + T + F | F + S + C + T | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gender | Age group |
|
|
|
|
|
|
|
|
|
|
|
|
| Male | < 1 | 1 (3.7) | 0 (0.0) | 0 (0.0) | 1 (0.1) | 1 (0.9) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 |
| 1–15 | 2 (7.4) | 2 (1.9) | 52 (24.6) | 46 (3.4) | 8 (7.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 6 (5.7) | 0 (0.0) | 0 (0.0) | 116 | |
| 16–30 | 1 (3.7) | 6 (5.6) | 17 (8.1) | 106 (7.8) | 6 (5.5) | 1 (33.3) | 3 (20.0) | 0 (0.0) | 9 (8.5) | 0 (0.0) | 0 (0.0) | 149 | |
| 31–45 | 6 (22.2) | 23 (21.5) | 23 (10.9) | 232 (17.0) | 14 (12.7) | 0 (0.0) | 1 (6.7) | 0 (0.0) | 16 (15.1) | 1 (100.0) | 0 (0.0) | 316 | |
| 46–60 | 2 (7.4) | 17 (15.9) | 10 (4.7) | 163 (12.0) | 15 (13.6) | 0 (0.0) | 2 (13.3) | 1 (50.0) | 7 (6.6) | 0 (0.0) | 1 (20.0) | 218 | |
| 61–75 | 0 (0.0) | 3 (2.8) | 2 (0.9) | 51 (3.7) | 5 (4.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 7 (6.6) | 0 (0.0) | 1 (20.0) | 69 | |
| 76–90 | 0 (0.0) | 0 (0.0) | 1 (0.5) | 17 (1.2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.9) | 0 (0.0) | 0 (0.0) | 19 | |
| > 90 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | |
| Female | < 1 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (0.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 |
| 1–15 | 1 (3.7) | 1 (0.9) | 14 (6.6) | 50 (3.7) | 3 (2.7) | 1 (33.3) | 1 (6.7) | 0 (0.0) | 2 (1.9) | 0 (0.0) | 0 (0.0) | 73 | |
| 16–30 | 5 (18.5) | 13 (12.1) | 21 (10.0) | 141 (10.4) | 9 (8.2) | 0 (0.0) | 2 (13.3) | 0 (0.0) | 8 (7.5) | 0 (0.0) | 0 (0.0) | 199 | |
| 31–45 | 7 (25.9) | 22 (20.6) | 40 (19.0) | 284 (20.9) | 19 (17.3) | 1 (33.3) | 2 (13.3) | 1 (50.0) | 26 (24.5) | 0 (0.0) | 0 (0.0) | 402 | |
| 46–60 | 1 (3.7) | 14 (13.1) | 29 (13.7) | 210 (15.4) | 26 (23.6) | 0 (0.0) | 2 (13.3) | 0 (0.0) | 13 (12.3) | 0 (0.0) | 2 (40.0) | 297 | |
| 61–75 | 0 (0.0) | 5 (4.7) | 1 (0.5) | 48 (3.5) | 2 (1.8) | 0 (0.0) | 2 (13.3) | 0 (0.0) | 9 (8.5) | 0 (0.0) | 1 (20.0) | 68 | |
| 76–90 | 1 (3.7) | 1 (0.9) | 1 (0.5) | 9 (0.7) | 2 (1.8) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (1.9) | 0 (0.0) | 0 (0.0) | 16 | |
| > 90 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (0.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 | |
| Total | 27 | 107 | 211 | 1,362 | 110 | 3 | 15 | 2 | 106 | 1 | 5 | 1,949 | |
Abbreviations: F fascioliasis, T toxocariasis, S strongyloidiasis, C cysticercosis